Your browser doesn't support javascript.
loading
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Howard, Robert; Cort, Elizabeth; Bradley, Rosie; Harper, Emma; Kelly, Linda; Bentham, Peter; Ritchie, Craig; Reeves, Suzanne; Fawzi, Waleed; Livingston, Gill; Sommerlad, Andrew; Oomman, Sabu; Nazir, Ejaz; Nilforooshan, Ramin; Barber, Robert; Fox, Chris; Macharouthu, Ajay Verma; Ramachandra, Pranathi; Pattan, Vivek; Sykes, John; Curran, Val; Katona, Cornelius; Dening, Tom; Knapp, Martin; Gray, Richard.
Afiliación
  • Howard R; Division of Psychiatry, University College London, London, UK. Electronic address: robert.howard@ucl.ac.uk.
  • Cort E; Department of Old Age Psychiatry, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK.
  • Bradley R; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Harper E; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Kelly L; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Bentham P; Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK.
  • Ritchie C; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
  • Reeves S; Division of Psychiatry, University College London, London, UK.
  • Fawzi W; Mile End Hospital, East London NHS Foundation Trust, London, UK.
  • Livingston G; Division of Psychiatry, University College London, London, UK; Camden and Islington NHS Foundation Trust, London, UK.
  • Sommerlad A; Division of Psychiatry, University College London, London, UK.
  • Oomman S; Cheshire and Wirral NHS Foundation Trust, Cheshire, UK.
  • Nazir E; South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Shrewsbury, UK.
  • Nilforooshan R; Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK.
  • Barber R; Northumberland Tyne and Wear NHS Foundation Trust, Newcastle, UK.
  • Fox C; Norwich Medical School, University of East Anglia, Norwich, UK; Norfolk & Suffolk NHS Foundation Trust, Norwich, UK.
  • Macharouthu AV; NHS Ayrshire & Arran, Kilmarnock, UK.
  • Ramachandra P; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Pattan V; NHS Forth Valley, Larbert, UK.
  • Sykes J; Derbyshire Healthcare NHS Foundation Trust, Derby, UK.
  • Curran V; Edward Street Hospital, West Bromwich, UK.
  • Katona C; Division of Psychiatry, University College London, London, UK.
  • Dening T; Division of Psychiatry and Applied Psychology, University of Nottingham, Nottingham, UK.
  • Knapp M; Department of Health Policy, London School of Economics and Political Science, London, UK.
  • Gray R; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Lancet Psychiatry ; 5(7): 553-563, 2018 07.
Article en En | MEDLINE | ID: mdl-29880238
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Antipsicóticos / Amisulprida Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Antipsicóticos / Amisulprida Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido